15
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Late diagnosis of partial 3 β-hydroxysteroid dehydrogenase type 2 deficiency – characterization of a new genetic variant

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Summary

          Congenital adrenal hyperplasia (CAH) is one of the most common inherited rare endocrine disorders. This case report presents two female siblings with delayed diagnosis of non-classical CAH 3 β-hydroxysteroid dehydrogenase type 2 (3 βHSD2D/ HSD3B2) despite early hospital admission and apparent CAH manifestations such as infections, hirsutism, menstrual disturbances, and PCOS phenotype. Initially, sister 1 was misdiagnosed with PCOS and then 11-hydroxylase deficiency ( CYP11B1), based on ultrasound, biochemical findings, and negative genetic testing for 21-hydroxylase deficiency ( CYP21A2). Additional diagnostic workup was performed when sister 2also presented with symptoms of androgen excess . Genetic testing for CAH/steroid disorders finally revealed that both siblings were compound heterozygous for two variants in the HSD3B2 gene: a frameshift variant, c.558dup, p.(Thr187Hisfs*17) and a novel missense variant, c.65T>C, p.(Leu22Ser). A Synacthen test showed an insufficient cortisol increase. In vitro studies of the variants in a cell model revealed loss of function for the p.(Thr187Hisfs*17) and partial activity for p.(Leu22Ser) confirming non-classic CAH. Overlapping symptomatology and lack of specialized knowledge on steroid biosynthesis and associated rarest forms of CAH may explain the delayed diagnosis. However, with newer diagnostic methods comprising a less biased approach, very rare forms of non-classical CAH may no longer be overlooked in the future.

          Learning points
          • Non-classic 3 βHSD2 is likely underdiagnosed.

          • Late diagnosis of mild non-classic 3 βHSD2 does occur and one should be aware of this diagnosis.

          • Early diagnosis of NCCAH may prevent many consequences such as severe hirsutism, prolonged menstrual irregularities, infertility, or even adrenal crisis with severe infections.

          • Comprehensive steroid profiling and genetic testing should be used earlier, especially when in doubt about a diagnosis.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management

          Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders affecting cortisol biosynthesis. Reduced activity of an enzyme required for cortisol production leads to chronic overstimulation of the adrenal cortex and accumulation of precursors proximal to the blocked enzymatic step. The most common form of CAH is caused by steroid 21-hydroxylase deficiency due to mutations in CYP21A2. Since the last publication summarizing CAH in Endocrine Reviews in 2000, there have been numerous new developments. These include more detailed understanding of steroidogenic pathways, refinements in neonatal screening, improved diagnostic measurements utilizing chromatography and mass spectrometry coupled with steroid profiling, and improved genotyping methods. Clinical trials of alternative medications and modes of delivery have been recently completed or are under way. Genetic and cell-based treatments are being explored. A large body of data concerning long-term outcomes in patients affected by CAH, including psychosexual well-being, has been enhanced by the establishment of disease registries. This review provides the reader with current insights in CAH with special attention to these new developments.
            • Record: found
            • Abstract: not found
            • Article: not found

            Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

              • Record: found
              • Abstract: found
              • Article: not found

              MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency

              Non-classic congenital adrenal hyperplasia (NCAH) is a relatively common disorder regardless of ethnicity, but most cases are never diagnosed, especially in males. A baseline 17-hydroxyprogesterone measurement may be used for screening, but 17-hydroxyprogesterone measurement after ACTH stimulation is the gold standard. We advocate a CYP21A2 mutation analysis to verify the diagnosis, for genetic counselling and for better prognostic and treatment guidance. Most patients are diagnosed in adolescence and adult life with hirsutism, acne, a PCOS-like picture and fertility issues. Many men with NCAH never seek medical attention and escape diagnosis. Although treatment is somewhat controversial, an early diagnosis and start of treatment may have positive implications on growth and be relevant for preventing and ameliorating the symptoms and consequences of androgen excess that develop over time, including fertility issues. Long-term treatment with glucocorticoids will improve the androgen symptoms but may result in long-term complications, such as obesity, insulin resistance, hypertension, osteoporosis and fractures. The glucocorticoid doses should be kept low. However, complications seen in NCAH, assumed to be caused by the glucocorticoid treatment, may also be associated with long-term androgen exposure. Oral contraceptive pills are a common treatment option for young females with NCAH. Regular clinical monitoring to improve the clinical outcome is recommended. It is important to acknowledge that glucocorticoid treatment will lead to secondary cortisol insufficiency and the need for stress dosing. Studies focusing on the specific difficulties patients with NCAH face, both those with a late clinical diagnosis and those with a neonatal diagnosis obtained by screening, are warranted.

                Author and article information

                Journal
                Endocrinol Diabetes Metab Case Rep
                Endocrinol Diabetes Metab Case Rep
                EDM
                Endocrinology, Diabetes & Metabolism Case Reports
                Bioscientifica Ltd (Bristol )
                2052-0573
                01 August 2024
                01 July 2024
                : 2024
                : 3
                : 23-0090
                Affiliations
                [1 ]Department of Endocrinology , Aarhus University Hospital, Aarhus N, Denmark
                [2 ]Department of Clinical Biochemistry , Aarhus University Hospital, Aarhus N, Denmark
                [3 ]Division of Pediatric Endocrinology , Diabetology and Metabolism, Department of Pediatrics, Bern University Hospital, University of Bern, Switzerland
                [4 ]Department of Biomedical Research , University of Bern, Switzerland
                [5 ]Kuopio Pediatric Research Unit (KuPRu) , University of Eastern Finland, Kuopio, Finland
                [6 ]Department of Nephrology , Bern University Hospital, University of Bern, Switzerland
                [7 ]Graduate School of Cellular and Biomedical Sciences , University of Bern, Switzerland
                [8 ]Department of Paediatrics , Odense University Hospital, Odense, Denmark
                [9 ]Department of Molecular Medicine , Aarhus University Hospital, Aarhus N, Denmark
                [10 ]Department of Clinical Genetics , Odense University Hospital, Odense, Denmark
                [11 ]Department of Clinical Research , University of Southern Denmark, Odense, Denmark
                [12 ]Department of Clinical Medicine , Aarhus University Hospital, Aarhus N, Denmark
                Author notes
                Correspondence should be addressed to C Gravholt: ch.gravholt@ 123456dadlnet.dk
                Author information
                http://orcid.org/0000-0001-5924-1720
                Article
                EDM23-0090
                10.1530/EDM-23-0090
                11301563
                39089319
                31751693-d7db-48be-a5b6-0b63459c8c5a
                © the author(s)

                This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

                History
                : 09 August 2023
                : 12 July 2024
                Funding
                Funded by: Novo Nordisk, doi http://dx.doi.org/10.13039/501100004191;
                Funded by: Familien Hede Nielsens Fond, doi http://dx.doi.org/10.13039/501100007438;
                Categories
                Adult
                Female
                White
                Denmark
                Adrenal
                Adrenal
                Genetics and Mutation
                Insight into Disease Pathogenesis or Mechanism of Therapy
                Insight into Disease Pathogenesis or Mechanism of Therapy

                adult,female,white,denmark,adrenal,genetics and mutation,insight into disease pathogenesis or mechanism of therapy,august,2024

                Comments

                Comment on this article

                Related Documents Log